-transparent.png){kind=logo}
Calciphylaxis is a challenging complication of end-stage renal disease, with an unknown underlying mechanism. Several risk factors have been identified, such as hyperphosphatemia, hypercalcemia, hyperparathyroidism, low serum albumin levels, and history of warfarin therapy. This article presents a case of calciphylaxis provoked by reintroduction of warfarin therapy, introducing the possibility of direct induction.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
July 2010,
Journal of drugs in dermatology : JDD,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
June 2002,
African journal of medicine and medical sciences,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
January 2007,
Cirugia y cirujanos,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
April 2009,
Experimental and molecular pathology,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
January 2012,
Internal medicine (Tokyo, Japan),
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
March 2021,
The breast journal,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
September 2016,
The breast journal,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
August 2023,
Clinical nephrology,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
September 2023,
Cureus,
Chadi Saifan, and
Marc Saad, and
Elie El-Charabaty, and
Suzanne El-Sayegh
January 2016,
BMJ case reports,
